Metabolically stabilized oxyalkylene esters and uses thereof
    1.
    发明授权
    Metabolically stabilized oxyalkylene esters and uses thereof 失效
    代谢稳定的氧化烯酯及其用途

    公开(公告)号:US06110955A

    公开(公告)日:2000-08-29

    申请号:US814975

    申请日:1997-03-11

    摘要: This invention relates to compositions for and methods of treating, preventing or ameliorating cancer and other proliferative diseases as well as methods of inducing wound healing, treating cutaneous ulcers, treating gastrointestinal disorders, treating blood disorders such as anemias, immunomodulation, enhancing recombinant gene expression, treating insulin-dependent patients, treating cystic fibrosis patients, inhibiting telomerase activity, treating virus-associated tumors, especially EBV-associated tumors, modulating gene expression and particularly augmenting expression of a tumor suppressor gene, inducing tolerance to an antigen and treating, ameliorating or preventing protozoan infection. The methods of the invention use metabolically stabilized oxyalkylene esters.

    摘要翻译: 本发明涉及治疗,预防或改善癌症和其它增殖性疾病的组合物和方法,以及诱导伤口愈合,治疗皮肤溃疡,治疗胃肠道疾病,治疗血液病症如贫血,免疫调节,增强重组基因表达的方法, 治疗胰岛素依赖型患者,治疗囊性纤维化患者,抑制端粒酶活性,治疗病毒相关肿瘤,特别是EBV相关肿瘤,调节基因表达,特别是增加肿瘤抑制基因的表达,诱导对抗原的耐受和治疗,改善或改善 预防原生动物感染。 本发明的方法使用代谢稳定的氧化亚烷基酯。

    Methods of using carboxylic acid esters to increase fetal-hemoglobin
levels
    7.
    发明授权
    Methods of using carboxylic acid esters to increase fetal-hemoglobin levels 失效
    使用羧酸酯增加胎儿血红蛋白水平的方法

    公开(公告)号:US5569675A

    公开(公告)日:1996-10-29

    申请号:US206690

    申请日:1994-03-07

    摘要: This invention relates to novel methods of increasing the level of fetal hemoglobin (HbF) in a subject and methods of treating, preventing or ameliorating .beta.-globin or other HbF-related disorders by increasing the level of HbF in a subject in need of such treatment comprising administering one or more compounds of the Formulae (I), (II), or (III):(I) XCH.sub.2 --CHX--CHX--C(.dbd.O)--O--Z(II) CH.sub.3 --CO--CH.sub.2 --C(.dbd.O)--O--Z(III) CH.sub.3 --CH.sub.2 --CO--C(.dbd.O)--O--Zwherein:X is H, or one of X only may be OH;Z is --CHR--O--C(.dbd.O)R', --CHR--O--C(.dbd.O)--O--R', or ##STR1## R is H, alkyl, aryl, arylalkyl; and R' is alkyl, aminoalkyl, aralkyl, aryl, alkoxy, aralkoxy and aryloxy, in which aryl by itself, and aryl in aralkyl, aralkoxy and aryloxy are each selected from the group consisting of phenyl, naphthyl, furyl, or thienyl, each of which is unsubstituted or substituted by at least one substituent selected from the group consisting of alkyl, alkoxy, or halogen; and pharmaceutically acceptable salts and prodrugs thereof.

    摘要翻译: 本发明涉及增加受试者胎儿血红蛋白(HbF)水平的新方法和通过增加需要这种治疗的受试者中HbF水平来治疗,预防或改善β-珠蛋白或其他HbF相关疾病的方法 包括施用一种或多种式(I),(II)或(III)的化合物:(I)XCH 2 -CHX-CHX-C(= O)-OZ(II)CH 3 -CO-CH 2 -C O)-OZ(III)CH 3 -CH 2 -CO-C(= O)-OZ其中:X是H,或者X中的一个可以是OH; Z是-CHR-O-C(= O)R',-CHR-O-C(= O)-O-R',或者R是H,烷基,芳基,芳基烷基; 和R'是烷基,氨基烷基,芳烷基,芳基,烷氧基,芳烷氧基和芳氧基,其中芳基本身和芳烷基,芳烷氧基和芳氧基中的芳基各自选自苯基,萘基,呋喃基或噻吩基,各自 其中未取代或被至少一个选自烷基,烷氧基或卤素的取代基取代; 及其药学上可接受的盐和前药。